| |
| Device | Radiesse (+) Injectable Implant |
| Generic Name | Implant, dermal, for aesthetic use |
| Applicant | Merz North America, Inc. 4133 Ct.ney Rd., Suite 10 Franksville, WI 53126 |
| PMA Number | P050052 |
| Supplement Number | S129 |
| Date Received | 12/03/2020 |
| Decision Date | 09/01/2021 |
| Product Code |
LMH |
| Docket Number | 21M-0975 |
| Notice Date | 09/03/2021 |
| Advisory Committee |
General & Plastic Surgery |
| Supplement Type | Panel Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval for Radiesse (+) injectable implant for expanding the indications to include deep injection (subdermal and/or supraperiosteal) for soft tissue augmentation to improve moderate to severe loss of jawline contour in adults over the age of 21 |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Post-Approval Study | Show Report Schedule and Study Progress |